Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $1,549,944 |
Sells | 169 | $15,948,143 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
09 Aug 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 07 Aug 2023 | Sale | 541 | 16.2451 | 8,789 | D |
09 Aug 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 07 Aug 2023 | Sale | 9,742 | 15.4785 | 150,792 | D |
08 Sep 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 07 Sep 2023 | Sale | 30 | 15.01 | 450 | D |
08 Sep 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Sep 2023 | Sale | 3,931 | 15.0564 | 59,187 | D |
03 Nov 2023 17:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Nov 2023 | Sale | 1,092 | 10.42 | 11,379 | D |
03 Nov 2023 17:00 | AVTE | Aerovate Therapeutics Inc | VERWIJS MARINUS | CHIEF TECHNOLOGY OFFICER | 01 Nov 2023 | Sale | 970 | 10.4625 | 10,149 | D |
27 Nov 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 22 Nov 2023 | Sale | 13,800 | 15 | 207,000 | D |
27 Nov 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 24 Nov 2023 | Sale | 70 | 16.0656 | 1,125 | D |
27 Nov 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 24 Nov 2023 | Sale | 4,920 | 15.7364 | 77,423 | D |
27 Nov 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 22 Nov 2023 | Sale | 9,382 | 15.1736 | 142,359 | D |
29 Nov 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 27 Nov 2023 | Sale | 12,517 | 16.2369 | 203,237 | D |
07 Dec 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Dec 2023 | Sale | 10,283 | 16.107 | 165,628 | D |
07 Dec 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Dec 2023 | Sale | 4,600 | 16.3034 | 74,996 | D |
15 Dec 2023 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 14 Dec 2023 | Sale | 9,897 | 19.5 | 192,992 | D |
15 Dec 2023 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 13 Dec 2023 | Sale | 2,103 | 19.5 | 41,008 | D |
22 Dec 2023 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 20 Dec 2023 | Sale | 4,000 | 19.5 | 78,000 | D |
29 Dec 2023 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 27 Dec 2023 | Sale | 125 | 24.5 | 3,062 | D |
08 Jan 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Jan 2024 | Sale | 2,474 | 19.5718 | 48,421 | D |
08 Jan 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Jan 2024 | Sale | 2,126 | 18.6713 | 39,695 | D |
19 Jan 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 17 Jan 2024 | Sale | 4,000 | 19.5 | 78,000 | D |
07 Feb 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Feb 2024 | Sale | 4,600 | 17.4455 | 80,249 | D |
22 Feb 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 20 Feb 2024 | Sale | 2,591 | 20.1068 | 52,097 | D |
22 Feb 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 20 Feb 2024 | Sale | 898 | 20.5766 | 18,478 | D |
27 Feb 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 23 Feb 2024 | Sale | 511 | 19.5 | 9,964 | D |
11 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 07 Mar 2024 | Sale | 8,975 | 24.5 | 219,888 | D |
11 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 11 Mar 2024 | Sale | 10 | 26.305 | 263 | D |
11 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 11 Mar 2024 | Sale | 3,423 | 25.2423 | 86,404 | D |
11 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 08 Mar 2024 | Sale | 114 | 25 | 2,850 | D |
11 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 07 Mar 2024 | Sale | 22,386 | 25.0017 | 559,688 | D |
14 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 12 Mar 2024 | Sale | 2,051 | 25.0461 | 51,370 | D |
14 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 13 Mar 2024 | Sale | 2,016 | 25.0223 | 50,445 | D |
20 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 18 Mar 2024 | Sale | 7,581 | 26.4825 | 200,764 | D |
20 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 18 Mar 2024 | Sale | 27,476 | 25.7418 | 707,282 | D |
20 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 18 Mar 2024 | Sale | 613 | 26.4022 | 16,185 | D |
20 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 18 Mar 2024 | Sale | 6,387 | 25.8137 | 164,872 | D |
20 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | VERWIJS MARINUS | CHIEF TECHNICAL OFFICER | 19 Mar 2024 | Sale | 2,764 | 26.4558 | 73,124 | D |
20 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | VERWIJS MARINUS | CHIEF TECHNICAL OFFICER | 19 Mar 2024 | Sale | 2,536 | 25.6779 | 65,119 | D |
27 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 25 Mar 2024 | Sale | 3,432 | 28.0068 | 96,119 | D |
28 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 27 Mar 2024 | Sale | 11,068 | 27.9652 | 309,519 | D |
01 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 28 Mar 2024 | Sale | 9,000 | 29.5 | 265,500 | D |
03 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 01 Apr 2024 | Sale | 12,495 | 31.2291 | 390,208 | D |
03 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | VERWIJS MARINUS | CHIEF TECHNICAL OFFICER | 01 Apr 2024 | Sale | 1,504 | 29.999 | 45,118 | D |
03 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | VERWIJS MARINUS | CHIEF TECHNICAL OFFICER | 01 Apr 2024 | Sale | 3,796 | 28.8669 | 109,579 | D |
03 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 01 Apr 2024 | Sale | 3,325 | 31.9749 | 106,317 | D |
03 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Apr 2024 | Sale | 1,000 | 31.95 | 31,950 | D |
03 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Apr 2024 | Sale | 1,647 | 29.8955 | 49,238 | D |
03 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Apr 2024 | Sale | 2,851 | 31.0228 | 88,446 | D |
03 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Apr 2024 | Sale | 4,502 | 28.9647 | 130,399 | D |
11 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GRAYZEL DAVID S. | Director | 09 Apr 2024 | Sale | 11,882 | 28.15 | 334,478 | I |
12 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 10 Apr 2024 | Sale | 771 | 27.5646 | 21,252 | D |
12 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 10 Apr 2024 | Sale | 6,729 | 26.7706 | 180,139 | D |
18 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 16 Apr 2024 | Sale | 5,509 | 24.9428 | 137,410 | D |
18 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 16 Apr 2024 | Sale | 4,491 | 24.3956 | 109,561 | D |
19 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 17 Apr 2024 | Sale | 311 | 23.3277 | 7,255 | D |
19 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 17 Apr 2024 | Sale | 3,689 | 22.3006 | 82,267 | D |
19 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 17 Apr 2024 | Sale | 68 | 23.97 | 1,630 | D |
19 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 17 Apr 2024 | Sale | 338 | 23.1699 | 7,831 | D |
19 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 17 Apr 2024 | Sale | 6,447 | 22.3151 | 143,865 | D |
03 May 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 May 2024 | Sale | 1,357 | 19.91 | 27,018 | D |
03 May 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 May 2024 | Sale | 965 | 20.8653 | 20,135 | D |
03 May 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 May 2024 | Sale | 9,035 | 20.3423 | 183,793 | D |
03 May 2024 18:00 | AVTE | Aerovate Therapeutics Inc | VERWIJS MARINUS | CHIEF TECHNICAL OFFICER | 02 May 2024 | Sale | 1,981 | 21.015 | 41,631 | D |
17 May 2024 19:10 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 16 May 2024 | Sale | 1,293 | 21.922 | 28,345 | D |
17 May 2024 19:10 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 16 May 2024 | Sale | 8,707 | 21.5241 | 187,410 | D |
17 May 2024 19:10 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 17 May 2024 | Sale | 86 | 21.86 | 1,880 | D |
17 May 2024 19:10 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 17 May 2024 | Sale | 3,914 | 21.0658 | 82,452 | D |
14 Jun 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 13 Jun 2024 | Sale | 6,000 | 24.5 | 147,000 | D |
14 Jun 2024 18:00 | AVTE | Aerovate Therapeutics Inc | VERWIJS MARINUS | CHIEF TECHNICAL OFFICER | 14 Jun 2024 | Sale | 10,600 | 25 | 265,000 | D |
14 Jun 2024 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 14 Jun 2024 | Sale | 15,000 | 25.03 | 375,450 | D |
20 Jun 2024 17:56 | AVTE | Aerovate Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 17 Jun 2024 | Purchase | 928,110 | 1.67 | 1,549,944 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)